Browsing: Eli

In a recent statement, Dave Ricks, CEO of Eli Lilly and Company, addressed national security concerns surrounding the importation of…

Eli Lilly has recently announced financial results for the first quarter, showcasing significant growth driven by its popular diabetes and…

In the world of finance this week, major companies have reported their latest earnings, spurring fluctuations in stock prices across…

Eli Lilly, the pharmaceutical giant known for its weight loss drug Zepbound and diabetes treatment Mounjaro, has initiated legal action…

Eli Lilly and Co. has announced a major milestone in diabetes treatment with the success of its Phase 3 clinical…

Eli Lilly, a prominent biopharmaceutical company, has initiated legal action against two compounding pharmacies in an effort to protect its…

Eli Lilly is poised to potentially revolutionize the weight loss drug market with the upcoming introduction of orforglipron, a once-daily…

Eli Lilly, a major player in the pharmaceutical industry, announced on Wednesday its plans to invest at least $27 billion…

In a significant shift within the pharmaceutical industry, Eli Lilly’s chief scientific officer, Dan Skovronsky, has revealed ambitious plans to…

Eli Lilly, a leading pharmaceutical company, is poised to make significant advancements in the medical field, particularly in challenging areas…